Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors
Monoclonal antibodies (mAbs) are one of the cornerstones of modern medicine, across an increasing range of therapeutic areas. All therapeutic mAbs are glycoproteins, i.e., their polypeptide chain is decorated with glycans, oligosaccharides of extraordinary structural diversity. The presence, absence...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2021-11-01
|
| Sarja: | Antibodies |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2073-4468/10/4/44 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|